Michael Rudnicki is a Senior Scientist and Director at Ottawa Hospital Research Institute since June 2000. Michael is also the Chief Discovery Officer at Satellos Bioscience Inc. since May 2018 and the Scientific Director and CEO at Stem Cell Network since 2005. Previously, Michael held positions at McMaster University and Whitehead Institute, with a Doctor of Philosophy (PhD) in Molecular Biology from the University of Ottawa in 1988.
May, 2018 - present
Chief Discovery Officer at BioCryst Pharmaceuticals
SVP, Oncology Business Group, Chief Discovery Officer, Oncology Business Group-Japan & Asia Medical at Eisai
Chief Discovery Officer at MapLight Therapeutics
Chief Discovery Officer & Head of Chemistry at Accutar Biotech